The global AI in bioinformatics market represents the integration of artificial intelligence (AI) technologies into the field of bioinformatics, leveraging advanced algorithms and computational models to analyze biological data. This synergy aims to enhance the efficiency and accuracy of processing vast datasets generated in genomics, proteomics, and other life sciences domains. AI applications in bioinformatics encompass predictive modeling, data interpretation, and pattern recognition, facilitating insights into complex biological phenomena.
Access Full Report @ https://www.databridgemarketresearch.com/ko/reports/global-ai-in-bioinformatics-market
Data Bridge Market Research analyses that the Global AI in Bioinformatics Market is expected to reach the value of USD 37,027.96 million by 2029, at a CAGR of 42.7% during the forecast period from 2022 to 2029 from USD 2,153.46 million in 2021. Growing acknowledgment by regulatory bodies underscores AI's crucial role in bioinformatics, fostering its development and integration into healthcare. This recognition promotes innovation, ensuring advanced technologies align with regulatory standards, and accelerating the adoption of AI-driven solutions in life sciences for enhanced diagnostics, drug discovery, and precision medicine applications.
Key Findings of the Study
Growing demand for bioinformatics is expected to drive the market's growth rate
Next-generation sequencing (NGS) is developing as a potent tool for offering a deeper and more precise insight into the molecular underpinnings of individual tumors and specific receptors as genomics-focused, pharmacology continues to play a greater role in the treatment of various chronic diseases, especially cancer. Informatics plays a vital role in biological research, including biologists who learn programming, computer programmers, mathematicians, or database managers to understand the basics of biology.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Offering (Software, Services, and Others), Type (Machine Learning, Deep Learning, and Others), Products and Services (Knowledge Management Tools, Bioinformatics Platforms and Bioinformatic Services), Application (Genomics, Microarrays, System Biology, Text Mining, Chemoinformatics and Drug Design, Proteomics, Transcriptomics, DNA Sequencing, Metabolomics and Others), Sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico in North America. U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe in Europe. China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific in Asia-Pacific. South Africa, Saudi Arabia, U.A.E., Israel, Egypt and Rest of Middle East and Africa (MEA) in Middle East and Africa. Brazil, Argentina and Rest of South America in South America.
|
|
Market Players Covered
|
JADBio & Gnosis Data Analysis (U.S.), SOPHiA GENETICS (U.K.), Biomax Informatics AG (Switzerland), DNASTAR (U.S.), Ardigen (France), QIAGEN (Germany), Source BioScience (U.K.), NeoGenomics Laboratories (U.S.), Eurofins Scientific (Luxembourg), Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), CelbridgeScience (U.S.), Dassault Systemes (France), Fios Genomics (U.K.), Insilico Medicine (U.S.), Strand Life Sciences (India), Paige AI, Inc. (U.S.), SomaLogic Operating Co., Inc. (U.S.), Elucidata (U.S.), and among others.
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global AI in bioinformatics market is categorized into five notable segments such as offering, type, products and services, application and sector.
- On the basis of offering, the global AI in bioinformatics market is segmented into software, services, and others. The services segment is expected to dominate the global AI in bioinformatics market with a 56.24% market share owing to a rise in platform applications
In 2022, the services segment is expected to dominate the global AI in bioinformatics market
The services segment is expected to dominate the global AI in bioinformatics market with a 56.24% market share owing to a rise in platform applications.
- On the basis of type, the global AI in bioinformatics market is segmented into machine learning, deep learning, and others. The machine learning segment is expected to dominate the global AI in the bioinformatics market with 70.39% market share due to increasing innovative technologies
- On the basis of products and services, the global AI in bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services. In 2022, the bioinformatics services segment is expected to dominate the global AI in bioinformatics market with a 59.22% market share due to rising demand for better bioinformatics tools
- On the basis of application, the global AI in bioinformatics market is segmented into genomics, microarrays, system biology, text mining, chemoinformatics and drug design, proteomics, transcriptomics, DNA sequencing, metabolomics, and others. In 2022, the genomics segment is expected to dominate the global AI in bioinformatics market with a 23.97% market share due to the rise in adoption of advanced technology
- On the basis of sector, the global AI in bioinformatics market is segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, and others. The medical biotechnology segment is expected to dominate the global AI in bioinformatics market with a 45.85% market share due to rising healthcare expenditure for better health services is also attributed to the growth of the market
In 2022, the medical biotechnology segment is expected to dominate the global AI in bioinformatics market
The medical biotechnology segment is expected to dominate the global AI in bioinformatics market with a 45.85% market share due to rising healthcare expenditure for better health services is also attributed to the growth of the market.
Major Players
Data Bridge Market Research recognizes the following companies as the major global AI in bioinformatics market players in global AI in bioinformatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), CelbridgeScience (U.S.), Dassault Systemes (France), Fios Genomics (U.K.), Insilico Medicine (U.S.), Strand Life Sciences (India), Paige AI, Inc. (U.S.), SomaLogic Operating Co., Inc. (U.S.), Elucidata (U.S.)
Market Developments
- In June 2022, Data-driven medicine pioneer SOPHiA GENETICS announced at the ESHG Conference in Vienna that its cloud-based SOPHiA DDMTM Platform, a supplement to diagnostic applications, has received CE-IVD certification for the analytical capability it supports. The SOPHiA DDMTM Platform is now IVD-ready to enable all applications and modules created for diagnostic purposes in the European Union and other markets recognizing this certification as a result of this certification. The company's global market presence has grown thanks to this
- In December 2021, JADBio and BioLizard announced their partnership. Agile bioinformatics and AI/ML business BioLizard serve clients in the pharmaceutical, biotechnology, and life sciences sectors. JADBio is a powerful Automated Machine Learning platform that enables the intuitive, prompt, interactive building of ML predictive models on BioMedical and Multi-omics data while enabling knowledge (biomarker signature) discovery through its broad range of reporting and analysis. This has aided the business in diversifying its offering of goods and services
- In April 2021, Biomax Informatics announced the launch of version 2.0 of AILANI. AILANI 2.0 represents an even modern and user-friendly version of Biomax Informatics' semantic search platform. Via the new AILANI Cloud Interface, users can quickly and cost-effectively search through numerous publicly accessible clinical studies, academic full-text documents and COVID-19-relevant patents, receiving intelligent responses to their questions alongside their keyword search. This has helped the company to increase its product portfolio in the market
Regional Analysis
Geographically, the countries covered in the global AI in bioinformatics market report are U.S., Canada, Mexico in North America. U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe in Europe. China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific in Asia-Pacific. South Africa, Saudi Arabia, U.A.E., Israel, Egypt and Rest of Middle East and Africa (MEA) in Middle East and Africa. Brazil, Argentina and Rest of South America in South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in global AI in bioinformatics market during the forecast period 2022-2029
North America is dominating the global AI in bioinformatics market, driven by a surge in demand for cutting-edge technology and accelerated drug development. To meet this rising demand, companies employ diverse strategies such as product launches, advancements, acquisitions, and more. These initiatives are anticipated to propel market growth by addressing the growing need for innovative solutions, establishing North America as a key hub for advancements in AI-driven bioinformatics applications.
For more detailed information about the global AI in bioinformatics market report, click here – https://www.databridgemarketresearch.com/ko/reports/global-ai-in-bioinformatics-market
